See also this year's filing and all EDGAR filings for this company.
PDF Report 0001633932_2023_ESSA_Pharma_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001633932, ESSA Pharma Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 169,059,341 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 445,954 |
| 4 | LiabilitiesCurrent | 2,310,399 |
| 5 | LiabilitiesNoncurrent | 76,418 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 12,544,760 |
| 9 | ResearchAndDevelopmentExpense | 24,415,246 |
| 10 | remainder_Expenses | -98,075 |
| 11 | remainder_Revenues | 1,736,641 |
| 12 | remainder_NetIncome | 22,039 |
| 13 | remainder_ComprehensiveNetIncome | -58,666 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 169,505,295 |
| 1 | Liabilities | 2,386,817 |
| 2 | Expenses | 36,861,931 |
| 3 | Revenues | 1,736,641 |
| 4 | StockholdersEquity | 167,118,478 |
| 5 | NetIncome | -35,103,251 |
| 6 | ComprehensiveNetIncome | -35,132,584 |
| 7 | BaseVar | 105,285,694 |
| 8 | EconomicCapitalRatio | 2.94 |